Net Income (Loss) Attributable to Parent in USD of Renalytix plc from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Renalytix plc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2018 to Q3 2024.
  • Renalytix plc Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was -$4.73M, a 53.4% increase year-over-year.
  • Renalytix plc Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$28M, a 36% increase year-over-year.
  • Renalytix plc annual Net Income (Loss) Attributable to Parent for 2024 was -$33.5M, a 26.6% increase from 2023.
  • Renalytix plc annual Net Income (Loss) Attributable to Parent for 2023 was -$45.6M, a 0.73% decline from 2022.
  • Renalytix plc annual Net Income (Loss) Attributable to Parent for 2022 was -$45.3M, a 28.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Renalytix plc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28M -$4.73M +$5.43M +53.4% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 -$33.5M -$7.07M +$4.03M +36.3% 01 Apr 2024 30 Jun 2024 10-K 30 Sep 2024
Q1 2024 -$37.5M -$7.74M +$4.36M +36% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$41.8M -$8.49M +$1.96M +18.8% 01 Oct 2023 31 Dec 2023 10-Q 15 May 2024
Q3 2023 -$43.8M -$10.2M +$1.8M +15.1% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024
Q2 2023 -$45.6M -$11.1M -$5.95M -115% 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024
Q1 2023 -$39.7M -$12.1M +$2.59M +17.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$42.2M -$10.4M +$4.88M +31.8% 01 Oct 2022 31 Dec 2022 10-Q 15 May 2024
Q3 2022 -$47.1M -$12M -$1.85M -18.3% 01 Jul 2022 30 Sep 2022 10-Q 15 May 2024
Q2 2022 -$45.3M -$5.15M +$4.67M +47.5% 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 -$49.9M -$14.7M -$5.92M -67.4% 01 Jan 2022 31 Mar 2022 6-K 09 Jun 2023
Q4 2021 -$44M -$15.3M -$6.2M -67.9% 01 Oct 2021 31 Dec 2021 6-K 09 Jun 2023
Q3 2021 -$37.8M -$10.1M -$2.49M -32.7% 01 Jul 2021 30 Sep 2021 6-K 09 Jun 2023
Q2 2021 -$35.3M -$9.82M 01 Apr 2021 30 Jun 2021 20-F 31 Oct 2022
Q1 2021 -$8.78M 01 Jan 2021 31 Mar 2021 6-K 30 Jun 2022
Q4 2020 -$9.13M 01 Oct 2020 31 Dec 2020 6-K 30 Jun 2022
Q3 2020 -$7.61M 01 Jul 2020 30 Sep 2020 6-K 30 Jun 2022
Q2 2018 -$572K 15 Mar 2018 30 Jun 2018 20-F/A 10 Nov 2020

Renalytix plc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$33.5M +$12.2M +26.6% 01 Jul 2023 30 Jun 2024 10-K 30 Sep 2024
2023 -$45.6M -$331K -0.73% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024
2022 -$45.3M -$9.94M -28.1% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023
2021 -$35.3M -$25.5M -259% 01 Jul 2020 30 Jun 2021 20-F 31 Oct 2022
2020 -$9.84M +$32.5M +76.7% 01 Jul 2019 30 Jun 2020 20-F 31 Oct 2022
2019 -$42.3M 01 Jul 2018 30 Jun 2019 20-F/A 01 Aug 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.